<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00575497</url>
  </required_header>
  <id_info>
    <org_study_id>SR002MFD</org_study_id>
    <nct_id>NCT00575497</nct_id>
  </id_info>
  <brief_title>More Frequent Dialysis (&gt;3 Treatments Per Week)</brief_title>
  <acronym>MFD</acronym>
  <official_title>Study of Clinical Outcomes of More Frequent Hemodialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Satellite Healthcare</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Satellite Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study compares the benefits of short daily hemodialysis six days a week, nocturnal (night
      time) hemodialysis six days a week, every other day and every other night hemodialysis to
      traditional three days a week hemodialysis.The hypothesis is that increasing hemodialysis
      treatment time and/or frequency will improve outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2005</start_date>
  <completion_date type="Anticipated">January 2010</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospitalization days per year</measure>
    <time_frame>Ongoing</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nutritional Status measured by Subjective Global Assessment</measure>
    <time_frame>Ongoing</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anemia, measured by erythropoetin dose</measure>
    <time_frame>Ongoing</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Control of hypertension, as measured by number of antihypertensive tablets taken per day</measure>
    <time_frame>Ongoing</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Control of hyperphosphatemia, as measured by number of phosphate binder tablets taken per day</measure>
    <time_frame>Ongoing</time_frame>
  </secondary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>End Stage Renal Disease</condition>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Six Day per week short daily hemodialysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Six nights per week nocturnal hemodialysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Every other day short daily hemodialysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Every other night hemodialysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 days per week short daily hemodialysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>F</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 nights per week hemodialysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>G</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional three time per week short daily hemodialysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>More frequent hemodialysis</intervention_name>
    <description>Six Day per week short daily hemodialysis</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>More frequent hemodialysis</intervention_name>
    <description>Six nights per week nocturnal hemodialysis</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>More frequent hemodialysis</intervention_name>
    <description>Every other day short daily hemodialysis</description>
    <arm_group_label>C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>More frequent hemodialysis</intervention_name>
    <description>Every other night hemodialysis</description>
    <arm_group_label>D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>More frequent hemodialysis</intervention_name>
    <description>5 days per week short daily hemodialysis</description>
    <arm_group_label>E</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>More frequent hemodialysis</intervention_name>
    <description>5 nights per week hemodialysis</description>
    <arm_group_label>F</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional Hemodialysis</intervention_name>
    <description>3 days per week short daily hemodialysis</description>
    <arm_group_label>G</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stable vascular access, i.e., lack of needling difficulties and stable flow rates.
             Accesses will include fistulae, grafts, catheters and ports.

          -  18 years of age.

          -  History of compliance with a dialysis treatment schedule, or if a new patient, express
             a willingness to be compliant with a treatment schedule.

          -  Plan to continue care and follow-up at the investigational site.

          -  Able to sign the informed consent and other relevant documents.

        Exclusion Criteria:

          -  History of poor compliance with thrice (or twice) weekly dialysis schedules as
             manifested by more than three unexplained missed treatments in the past six (6)
             months.

          -  Pregnancy.

          -  Intravenous drug abuser.

          -  Expects to receive a transplant or transfer to another facility within six months of
             entering the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Moran, MD</last_name>
    <role>Study Director</role>
    <affiliation>Satellite Healthcare, Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brigittte Schiller-Moran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Satellite Healthcare, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brigitte Schiller-Moran, MD</last_name>
    <phone>650-404-3640</phone>
    <email>schillerb@satellitehealth.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sheila J Doss, RN, CCRA</last_name>
    <phone>650-404-3621</phone>
    <email>dosss@satellitehealth.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Satellite Healthcare, Inc.</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <zip>64041</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheila J Doss, RN, CCRA</last_name>
      <phone>650-404-3621</phone>
      <email>dosss@satellitehealth.com</email>
    </contact>
    <investigator>
      <last_name>Brigitte Schiller-Moran, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>WellBound, Inc.</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <zip>94041</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Moran, MD</last_name>
      <phone>650-404-3620</phone>
      <email>moranj@satellitehealth.com</email>
    </contact>
    <contact_backup>
      <last_name>Sheila J Doss, RN, CCRA</last_name>
      <phone>650-404-3621</phone>
      <email>dosss@satellitehealth.com</email>
    </contact_backup>
    <investigator>
      <last_name>Brigitte Schiller-Moran, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2007</study_first_submitted>
  <study_first_submitted_qc>December 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2007</study_first_posted>
  <last_update_submitted>December 17, 2007</last_update_submitted>
  <last_update_submitted_qc>December 17, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 18, 2007</last_update_posted>
  <responsible_party>
    <name_title>Brigitte Schiller-Moran MD</name_title>
    <organization>Satellite Healthcare, Inc.</organization>
  </responsible_party>
  <keyword>Hemodialysis</keyword>
  <keyword>Adequacy</keyword>
  <keyword>Frequency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

